{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:05:33Z","timestamp":1793329533405,"version":"4.5.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1093\/jac\/dkr136","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T09:53:49Z","timestamp":1302602029000},"page":"1215-1222","source":"Crossref","is-referenced-by-count":103,"title":["Ribavirin for patients with Crimean\u2013Congo haemorrhagic fever: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"66","author":[{"given":"Sibel","family":"Ascioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Leblebicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Vahaboglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Arnold","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,11]]},"reference":[{"key":"key\n\t\t\t\t20170425162641_DKR136C1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-3542(04)00163-9","article-title":"Crimean-Congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20170425162641_DKR136C2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/QCO.0b013e3282a56a0a","article-title":"Crimean-Congo hemorrhagic fever","volume":"20","author":"Vorou","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Ergonul","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C4","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.10.19504-en","article-title":"Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness","volume":"15","author":"Maltezou","year":"2010","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170425162641_DKR136C5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3201\/eid1008.040162","article-title":"Crimean-Congo hemorrhagic fever in Bulgaria","volume":"10","author":"Papa","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijid.2008.11.011","article-title":"Crimean-Congo hemorrhagic fever in Greece: a public health perspective","volume":"13","author":"Maltezou","year":"2009","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1128\/JCM.40.3.1122-1123.2002","article-title":"Crimean-Congo hemorrhagic fever in Kosovo","volume":"40","author":"Drosten","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170425162641_DKR136C8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3201\/eid1506.081567","article-title":"Crimean-Congo hemorrhagic fever, Southwestern Bulgaria","volume":"15","author":"Christova","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1099\/jmm.0.45865-0","article-title":"Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures","volume":"54","author":"Bakir","year":"2005","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20170425162641_DKR136C10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.2005.72.471","article-title":"Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002: contact tracing and risk assessment","volume":"72","author":"Athar","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170425162641_DKR136C11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijid.2008.07.021","article-title":"The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002\u20132007","volume":"13","author":"Yilmaz","year":"2009","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1865-1682.2008.01028.x","article-title":"Surveillance and laboratory detection system of Crimean-Congo haemorrhagic fever in Iran","volume":"55","author":"Chinikar","year":"2008","journal-title":"Transbound Emerg Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C13","first-page":"E11","article-title":"Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses","volume":"9","author":"Bossi","year":"2004","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170425162641_DKR136C14","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170425162641_DKR136C15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev Med Virol"},{"key":"key\n\t\t\t\t20170425162641_DKR136C16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1086\/596310","article-title":"How medicine advances","volume":"48","author":"Chapman","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3810\/pgm.2009.05.2014","article-title":"Original research: intravenous ribavirin\u2014review of the FDA's Emergency Investigational New Drug Database (1997\u20132008) and literature review","volume":"121","author":"Riner","year":"2009","journal-title":"Postgrad Med"},{"key":"key\n\t\t\t\t20170425162641_DKR136C18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3476(94)70139-3","article-title":"Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial","volume":"125","author":"Rodriguez","year":"1994","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170425162641_DKR136C19","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.110.1.e9","article-title":"Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children","volume":"110","author":"Gavin","year":"2002","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170425162641_DKR136C20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/596309","article-title":"Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India","volume":"48","author":"Kumar","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1365-3156.2004.01281.x","article-title":"Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003","volume":"9","author":"Leong","year":"2004","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20170425162641_DKR136C22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America","volume":"39","author":"Mertz","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","article-title":"Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group","volume":"4","author":"Chapman","year":"1999","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170425162641_DKR136C24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"Huggins","year":"1991","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2007.11.002","article-title":"Treatment of Crimean-Congo hemorrhagic fever","volume":"78","author":"Ergonul","year":"2008","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20170425162641_DKR136C26","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/375058","article-title":"The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran","volume":"36","author":"Mardani","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/422000","article-title":"Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy","volume":"39","author":"Ergonul","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7883\/yoken.JJID.2009.11","article-title":"Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study","volume":"62","author":"Izadi","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C29","author":"World Health Organization"},{"key":"key\n\t\t\t\t20170425162641_DKR136C30","author":"European Center for Disease Prevention and Control"},{"key":"key\n\t\t\t\t20170425162641_DKR136C31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jinf.2009.01.014","article-title":"Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey","volume":"58","author":"Elaldi","year":"2009","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170425162641_DKR136C32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcv.2009.11.007","article-title":"The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey","volume":"47","author":"Koksal","year":"2010","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20170425162641_DKR136C33","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technol Assess"},{"key":"key\n\t\t\t\t20170425162641_DKR136C34","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170425162641_DKR136C35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170425162641_DKR136C36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170425162641_DKR136C37","volume-title":"Modern Epidemiology","author":"Rothman","year":"2008"},{"key":"key\n\t\t\t\t20170425162641_DKR136C38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2005.05.003","article-title":"Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy","volume":"52","author":"Ozkurt","year":"2006","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170425162641_DKR136C39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2005.07.015","article-title":"Crimean-Congo hemorrhagic fever in Southeast of Iran","volume":"52","author":"Alavi-Naini","year":"2006","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170425162641_DKR136C40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10096-009-0728-2","article-title":"The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising","volume":"28","author":"Tasdelen Fisgin","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2008.07.007","article-title":"A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever","volume":"57","author":"Cevik","year":"2008","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170425162641_DKR136C42","first-page":"151","article-title":"The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study","volume":"12","author":"Sharifi-Mood","year":"2009","journal-title":"Arch Iran Med"},{"key":"key\n\t\t\t\t20170425162641_DKR136C43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3923\/ijv.2006.21.24","article-title":"Clinical outcomes in Crimean-Congo hemorrhagic fever: a five-years experience in the treatment of patients with oral ribavirin","volume":"2","author":"Metanat","year":"2006","journal-title":"Int J Virol"},{"key":"key\n\t\t\t\t20170425162641_DKR136C44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1258\/td.2008.080092","article-title":"Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever","volume":"39","author":"Tasdelen Fisgin","year":"2009","journal-title":"Trop Doct"},{"key":"key\n\t\t\t\t20170425162641_DKR136C45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/bmj.309.6956.727","article-title":"Interpreting the results of observational research: chance is not such a fine thing","volume":"309","author":"Brennan","year":"1994","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170425162641_DKR136C46","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pmed.0050067","article-title":"Observational research, randomised trials, and two views of medical science","volume":"5","author":"Vandenbroucke","year":"2008","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170425162641_DKR136C47","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJM200006223422511","article-title":"Randomized trials or observational tribulations?","volume":"342","author":"Pocock","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425162641_DKR136C48","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/aje\/kwm189","article-title":"Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles","volume":"166","author":"Shrier","year":"2007","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170425162641_DKR136C49","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.286.7.821","article-title":"Comparison of evidence of treatment effects in randomized and nonrandomized studies","volume":"286","author":"Ioannidis","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170425162641_DKR136C50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9343(82)90815-4","article-title":"Randomized versus historical controls for clinical trials","volume":"72","author":"Sacks","year":"1982","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170425162641_DKR136C51","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.317.7167.1185","article-title":"The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials","volume":"317","author":"Kunz","year":"1998","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170425162641_DKR136C52","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200109203451211","article-title":"The ethics of placebo-controlled trials\u2014a middle ground","volume":"345","author":"Emanuel","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425162641_DKR136C53","author":"Declaration of Helsinki"},{"key":"key\n\t\t\t\t20170425162641_DKR136C54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-10-207","article-title":"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis","volume":"10","author":"Soares-Weiser","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.trstmh.2005.03.002","article-title":"Crimean-Congo hemorrhagic fever: experience at a tertiary care hospital in Karachi, Pakistan","volume":"99","author":"Jamil","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170425162641_DKR136C56","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/j.ijid.2009.02.011","article-title":"An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey","volume":"13","author":"Ertugrul","year":"2009","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170425162641_DKR136C57","first-page":"247","article-title":"A comparison of clinical and serological diagnosis in an epidemic of Crimean-Congo haemorrhagic fever","volume":"19","author":"Nadeem","year":"2003","journal-title":"Pakistani J Med Sci"},{"key":"key\n\t\t\t\t20170425162641_DKR136C58","article-title":"Effect of oral ribavirin treatment to the viral load and progress of the disease in Crimean-Congo hemorrhagic fever","author":"Bodur"},{"key":"key\n\t\t\t\t20170425162641_DKR136C59","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/sim.4780030421","article-title":"Why do we need some large, simple randomized trials?","volume":"3","author":"Yusuf","year":"1984","journal-title":"Stat Med"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/66\/6\/1215\/13760497\/dkr136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T07:43:58Z","timestamp":1686037438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkr136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,11]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,4,11]]},"published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkr136","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,11]]}}}